Therapeutic strategies in elderly and very elderly patients

Best Practice and Research: Clinical Haematology

Volumn 25, Issue 1, 2012, Pages 91-100

  Soubeyran, P ^a,b   Henriques De Figueiredo, B ^a   Soubeyran, I ^a   Mertens, C ^c   Cazeau, A L ^a  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

chemotherapy; elderly; frail; lymphoma; unfit

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; VINCRISTINE;

CANCER SURVIVAL; CAREGIVER; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUAL VALIDITY; ELDERLY CARE; GERIATRIC PATIENT; HEALTH STATUS; HUMAN; LYMPHOMA; METASTASIS; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; DIAGNOSTIC TESTS, ROUTINE; DOXORUBICIN; GERIATRIC ASSESSMENT; HUMANS; LYMPHOMA; PREDNISONE; QUESTIONNAIRES; RADIATION, IONIZING; VINCRISTINE;

EID: 84858300273     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2012.01.009     Document Type: Review

References (102)

1. P.N. Meyer, K. Fu, and T.C. Greiner Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab J Clin Oncol 29 2 2011 200 207
2. A. Rosenwald, G. Wright, and W.C. Chan The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 25 2002 1937 1947 (Pubitemid 34651353)
3. S. Mareschal, H. Lanic, and P. Ruminy The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age Haematologica 96 12 2011 1888 1890
4. K. Dunleavy, S. Pittaluga, and M.S. Czuczman Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Blood 113 24 2009 6069 6076
5. S.A. van de Schans, A.N. Wymenga, and D.J. van Spronsen Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma Ann Oncol 2011
6. B. Hoerni, J.J. Sotto, and H. Eghbali Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases Cancer 61 10 1988 2057 2059
7. S. Monfardini, S.M. Aversa, and V. Zoli Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas Ann Oncol 16 8 2005 1352 1358 (Pubitemid 41158481)
8. C. Thieblemont, A. Grossoeuvre, and R. Houot Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome Ann Oncol 19 4 2008 774 779 (Pubitemid 351461051)
9. P. Soubeyran, H. Khaled, and M. MacKenzie Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly: a phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment J Geriatr Oncol 2 1 2011 36 44
10. L.C. Walter, and K.E. Covinsky Cancer screening in elderly patients: a framework for individualized decision making JAMA 285 2001 2750 2756 (Pubitemid 32525372)
11. C.A. Townsley, K. Naidoo, and G.R. Pond Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns J Clin Oncol 21 24 2003 4627 4635
12. J.P. Berrios-Rivera, S. Fang, and M.E. Cabanillas Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma Am J Clin Oncol 30 2 2007 163 171 (Pubitemid 46573252)
13. J.E. Kurtz, D. Heitz, and P. Enderlin Geriatric oncology, general practitioners and specialists: current opinions and unmet needs Crit Rev Oncol/Hematol 75 1 2010 47 57
14. F. Delva, E. Marien, and M. Fonck Factors influencing general practitioners in the referral of elderly cancer patients BMC Cancer 11 1 2011 5
15. B.D. Cheson, B. Pfistner, and M.E. Juweid Revised response criteria for malignant lymphoma J Clin Oncol 25 5 2007 579 586 (Pubitemid 350002966)
16. M. Moreau, J. Klastersky, and A. Schwarzbold A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies Ann Oncol 20 3 2009 513 519
17. S. Scott Identification of cancer patients at high risk of febrile neutropenia Am J Health Syst Pharm 59 15 Suppl. 4 2002 S16 S19
18. A. Pinto, R. De Filippi, and F. Frigeri Aging and the hemopoietic system Crit Rev Oncol/Hematol 48 Supplement(0) 2003 S3 S12 (Pubitemid 37244166)
19. K. Spaepen, S. Stroobants, and P. Dupont Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma Ann Oncol 13 9 2002 1356 1363
20. C. Haioun, E. Itti, and A. Rahmouni [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome Blood 106 4 2005 1376 1381 (Pubitemid 41129604)
21. N.G. Mikhaeel, M. Hutchings, and P.A. Fields FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma Ann Oncol 16 9 2005 1514 1523 (Pubitemid 41222425)
22. E. Itti, C. Lin, and J. Dupuis Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy J Nucl Med 50 4 2009 527 533
23. H.S. Han, M.P. Escalon, and B. Hsiao High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens Ann Oncol 20 2 2009 309 318
24. C.H. Moskowitz, H. Schoder, and J. Teruya-Feldstein Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma J Clin Oncol 28 11 2010 1896 1903
25. P.L. Zinzani, A. Broccoli, and V. Stefoni Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients Cancer 116 24 2010 5667 5675
26. A.F. Cashen, F. Dehdashti, and J. Luo 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation J Nucl Med 52 3 2011 386 392
27. Y. Bastion, J.Y. Blay, and M. Divine Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival-a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years J Clin Oncol 15 8 1997 2945 2953 (Pubitemid 27330023)
28. B. Coiffier, E. Lepage, and J. Briere CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 4 2002 235 242 (Pubitemid 34438862)
29. E.M. Bessell, A. Burton, and A.P. Haynes A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma Ann Oncol 14 2 2003 258 267 (Pubitemid 36305438)
30. E. Osby, H. Hagberg, and S. Kvaloy CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial Blood 101 10 2003 3840 3848 (Pubitemid 36857855)
31. P. Feugier, H.A. Van, and C. Sebban Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 23 18 2005 4117 4126 (Pubitemid 46211317)
32. A. Italiano, F. Jardin, and F. Peyrade Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old Haematologica 90 9 2005 1281 1283 (Pubitemid 41375292)
33. O. Bairey, O. Benjamini, and D. Blickstein Non-Hodgkin's lymphoma in patients 80 years of age or older Ann Oncol 17 6 2006 928 934 (Pubitemid 43778982)
34. T.M. Habermann, E.A. Weller, and V.A. Morrison Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma J Clin Oncol 24 19 2006 3121 3127 (Pubitemid 46638950)
35. M. Pfreundschuh, J. Schubert, and M. Ziepert Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol 9 2 2008 105 116
36. B. Coiffier, C. Thieblemont, and N.E. Van Den Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Blood 116 12 2010 2040 2045
37. F. Peyrade, F. Jardin, and C. Thieblemont Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial Lancet Oncol 12 5 2011 460 468
38. R. Sawhney, M. Sehl, and A. Naeim Physiologic aspects of aging: impact on cancer management and decision making, part I Cancer J 11 6 2005 449 460 (Pubitemid 43097072)
39. M. Sehl, R. Sawhney, and A. Naeim Physiologic aspects of aging: impact on cancer management and decision making, part II Cancer J 11 6 2005 461 473 (Pubitemid 43097073)
40. S.M. Lichtman, H. Wildiers, and V. Launay-Vacher International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency Eur J Cancer 43 1 2007 14 34 (Pubitemid 46070218)
41. C. Blanc-Bisson, M. Fonck, and M. Rainfray Undernutrition in elderly patients with cancer: target for diagnosis and intervention Crit Rev Oncol Hematol 67 3 2008 243 254
42. S.J. Lee, K. Lindquist, and M.R. Segal Development and validation of a prognostic index for 4-year mortality in older adults JAMA 295 7 2006 801 808 (Pubitemid 43244307)
43. L.C. Walter, R.J. Brand, and S.R. Counsell Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization JAMA 285 2001 2987 2994 (Pubitemid 32550117)
44. E.C. Carey, K.E. Covinsky, and L.Y. Lui Prediction of mortality in community-living frail elderly people with long-term care needs J Am Geriatr Soc 56 1 2008 68 75
45. M. Extermann, and A. Hurria Comprehensive geriatric assessment for older patients with cancer J Clin Oncol 25 14 2007 1824 1831 (Pubitemid 46860271)
46. C. Terret, G.B. Zulian, and A. Naiem Multidisciplinary approach to the geriatric oncology patient J Clin Oncol 25 14 2007 1876 1881 (Pubitemid 46854421)
47. M. Extermann, J. Overcash, and G.H. Lyman Comorbidity and functional status are independent in older cancer patients J Clin Oncol 16 4 1998 1582 1587 (Pubitemid 28175784)
48. M.P. Lawton, and E.M. Brody Assessment of older people: self-maintaining and instrumental activities of daily living Gerontologist 9 3 1969 179 186
49. S. Katz, A.B. Ford, and R.W. Moskowitz Studies of illness in the aged. The index of ADL: a Standardized measure of biological and psychosocial function JAMA 185 1963 914 919
50. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 3 1975 189 198
51. J. Sheikh, and J.A. Yesavage Geriatric depression scale (GDS). Recent evidence and development of a shorter version Clin Gerontol 5 1986 165 171
52. Y. Guigoz, B. Vellas, and P.J. Garry Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients Facts Res Gerontol 4 suppl 2 1994 15 59
53. D. Podsiadlo, and S. Richardson The timed "Up & Go": a test of basic functional mobility for frail elderly persons J Am Geriatr Soc 39 2 1991 142 148
54. A.G. Pallis, U. Wedding, and D. Lacombe Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 46 6 2010 1019 1025
55. L. Repetto, L. Fratino, and R.A. Audisio Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study J Clin Oncol 20 2 2002 494 502 (Pubitemid 34072534)
56. R. Kanesvaran, H. Li, and K.N. Koo Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer J Clin Oncol 29 27 2011 3620 3627
57. Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, et al. Predictors of Early Death Risk in Older Patients Treated by First-line Chemotherapy for Cancer. J Clin Oncol, in press.
58. A.A. Aaldriks, E. Maartense, and S. le Cessie Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy Crit Rev Oncol Hematol 79 2011 205 212
59. D.B. Reuben, L.V. Rubenstein, and S.H. Hirsch Value of functional status as a predictor of mortality: results of a prospective study Am J Med 93 6 1992 663 669
60. A. Brouquet, T. Cudennec, and S. Benoist Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery Ann Surg 251 4 2010 759 765
61. M. Hamer, C.J. Bates, and G.D. Mishra Depression, physical function, and risk of mortality: national diet and nutrition survey in adults older than 65 years Am J Geriatr Psychiatry 19 1 2011 72 78
62. C. Wolfson, D.B. Wolfson, and M. Asgharian A reevaluation of the duration of survival after the onset of dementia N Engl J Med 344 15 2001 1111 1116 (Pubitemid 32285231)
63. T.E. Stump, C.M. Callahan, and H.C. Hendrie Cognitive impairment and mortality in older primary care patients J Am Geriatr Soc 49 7 2001 934 940 (Pubitemid 32743629)
64. M.W. Reynolds, L. Fredman, and P. Langenberg Weight, weight change, mortality in a random sample of older community-dwelling women J Am Geriatr Soc 47 12 1999 1409 1414
65. F. Buntinx, L. Niclaes, and C. Suetens Evaluation of Charlson's comorbidity index in elderly living in nursing homes J Clin Epidemiol 55 11 2002 1144 1147 (Pubitemid 36043992)
66. D. Saliba, M. Orlando, and N.S. Wenger Identifying a short functional disability screen for older persons J Gerontol A Biol Sci Med Sci 55 12 2000 M750 M756 (Pubitemid 32175759)
67. S.G. Mohile, K. Bylow, and W. Dale A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation Cancer 109 4 2007 802 810 (Pubitemid 46233244)
68. A. Luciani, G. Ascione, and C. Bertuzzi Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13 J Clin Oncol 28 12 2010 2046 2050
69. E. Kellen, P. Bulens, and L. Deckx Identifying an accurate pre-screening tool in geriatric oncology Crit Rev Oncol/Hematol 75 3 2010 243 248
70. M.J. Molina-Garrido, and C. Guillen-Ponce Comparison of two frailty screening tools in older women with early breast cancer Crit Rev Oncol/Hematol 79 1 2011 51 64
71. Bellera CA, Rainfray M, Mathoulin-Pelissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol, in press.
72. P. Soubeyran, C. Bellera, and J. Goyard Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project J Clin Oncol 29 15S Part I 2011 550s
73. A. Tucci, S. Ferrari, and C. Bottelli A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy Cancer 115 19 2009 4547 4553
74. P. Caillet, F. Canoui-Poitrine, and J. Vouriot Comprehensive geriatric assessment in the decision-making Process in elderly patients with cancer: ELCAPA study J Clin Oncol 29 27 2011 3636 3642
75. P. Chaibi, N. Magne, and S. Breton Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients Crit Rev Oncol Hematol 79 3 2011 302 307
76. L. Balducci, and M. Extermann Management of cancer in the older person: a practical approach Oncologist 5 3 2000 224 237 (Pubitemid 30429942)
77. M. Extermann, G. Albrand, and H. Chen Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 21 17 2003 3214 3219 (Pubitemid 46606252)
78. M.L. Slevin, L. Stubbs, and H.J. Plant Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public BMJ 300 6737 1990 1458 1460 (Pubitemid 20195333)
79. R.M. Bremnes, K. Andersen, and E.A. Wist Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy Eur J Cancer 31A 12 1995 1955 1959 (Pubitemid 26023084)
80. M. Pfreundschuh, L. Trumper, and M. Kloess Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL Blood 104 3 2004 634 641 (Pubitemid 38970554)
81. T.J. Smith, J. Khatcheressian, and G.H. Lyman 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based Clinical Practice Guideline J Clin Oncol 24 19 2006 3187 3205 (Pubitemid 46638957)
82. L. Repetto, L. Biganzoli, and C.H. Koehne EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer Eur J Cancer 39 16 2003 2264 2272 (Pubitemid 37214850)
83. J.K. Doorduijn, H.B. van der, and G.W. van Imhoff CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma J Clin Oncol 21 16 2003 3041 3050 (Pubitemid 46606283)
84. C. Bokemeyer, M.S. Aapro, and A. Courdi EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update Eur J Cancer 43 2 2007 258 270 (Pubitemid 46127840)
85. M.S. Aapro, G. Birgegard, and C. Bokemeyer Erythropoietins should be used according to guidelines Lancet Oncol 9 5 2008 412 413 (Pubitemid 351618079)
86. M. Aapro, C. Bernard-Marty, and E.G.C. Brain Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper Ann Oncol 22 2 2011 257 267
87. D.L. Hershman, R.B. McBride, and A. Eisenberger Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma J Clin Oncol 26 19 2008 3159 3165
88. T.P. Miller, S. Dahlberg, and J.R. Cassady Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma N Engl J Med 339 1 1998 21 26 (Pubitemid 28304493)
89. T.P. Miller, M. Leblanc, and C.M. Spier CHOP alone compared to CHOP plus radiotherapy foe early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial Blood 98 11 16-11-1998 724a 725a
90. S.J. Horning, E. Weller, and K. Kim Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484 J Clin Oncol 22 15 2004 3032 3038 (Pubitemid 41103714)
91. T.N. Shenkier, N. Voss, and R. Fairey Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency J Clin Oncol 20 1 2002 197 204 (Pubitemid 34032612)
92. A. Ballonoff, K.E. Rusthoven, and A. Schwer Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis Int J Radiat Oncol Biol Phys 72 5 2008 1465 1471
93. C. Bonnet, G. Fillet, and N. Mounier CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 25 7 2007 787 792 (Pubitemid 350002878)
94. D.O. Persky, J.M. Unger, and C.M. Spier Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014 J Clin Oncol 26 14 2008 2258 2263
95. A. Aviles, R. Fernandezb, and F. Perez Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome Leuk Lymphoma 45 7 2004 1385 1389 (Pubitemid 38701914)
96. R.B. Wilder, M.A. Rodriguez, and S.L. Tucker Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas Int J Radiat Oncol Biol Phys 50 3 2001 743 749 (Pubitemid 32515329)
97. A.J. Ferreri, S. Dell'Oro, and M. Reni Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas Oncology 58 3 2000 219 226 (Pubitemid 30189905)
98. C. Rube, T.P. Nguyen, and M. Kloss Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL Ann Hematol 80 Suppl. 3 2001 B84 B85
99. P.J. Schlembach, R.B. Wilder, and S.L. Tucker Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas Int J Radiat Oncol Biol Phys 48 4 2000 1107 1110
100. J. Phan, A. Mazloom, and M.L. Jeffrey Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy J Clin Oncol 28 27 2010 4170 4176
101. A. Aviles, N. Neri, and S. Delgado Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy Med Oncol 22 4 2005 383 387 (Pubitemid 43780295)
102. E.C. Moser, H.C. Kluin-Nelemans, and P. Carde Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 66 4 2006 1168 1177 (Pubitemid 44633498)